A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Pfizer
- Study ID
- NCT06989437
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Cachexia
- Metastatic Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ponsegromab — DRUGDouble-Blind ponsegromab Treatment
- placebo — DRUGDouble-Blind placebo Treatment
Study Details
Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic ductal adenocardinoma.
Key Dates
- Start date
- Oct 3, 2025
- Status verified
- Jun 2026
- Primary completion
- Jan 17, 2028
- Completion
- Dec 10, 2029
Study Design
- Enrollment
- 982 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Double-Blind ponsegromab Treatment lower doseponsegromab 200 mg subcutaneous injection every 4 weeks
- Experimental: Double-Blind ponsegromab Treatment higher doseponsegromab 400 mg subcutaneous injection every 4 weeks
- Placebo Comparator: Double-Blind Placebo TreatmentMatch placebo subcutaneous injection every 4 weeks
Primary Outcome Measure
Percent change from baseline in body weight for ponsegromab compared to placebo [ Time Frame: Baseline, Week 12 ]
Central Contacts
- Pfizer CT.gov Call Center1-800-718-1021
Locations (72)
Find similar trials in Birmingham, AL
By research site
The Kirklin Clinic of UAB Hospital· Birmingham, ALThe University of Alabama at Birmingham· Birmingham, ALCentral Arkansas Radiation Therapy Institute, dba CARTI· Bryant, ARCentral Arkansas Radiation Therapy Institute, dba CARTI· Conway, ARCARTI Cancer Center· Little Rock, ARCentral Arkansas Radiation Therapy Institute, dba CARTI· North Little Rock, AR
Related Studies
- Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal CancerPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Targeted Pathway Inhibition in Patients With Pancreatic CancerEARLY_PHASE1 · Recruiting · OHSU Knight Cancer Institute · Portland, Oregon
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsPHASE1 · Recruiting · General Oncology, Inc. · Boston, Massachusetts
- Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc AdenocarcinomaRecruiting · Wake Forest University Health Sciences · Charlotte, North Carolina